Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients

Xuexin He, Xiaolan Dai, Jiali Ji, Hong Liu, Ganggang Shi, Sai Ching Jim Yeung

    Research output: Contribution to journalArticlepeer-review

    6 Scopus citations

    Fingerprint

    Dive into the research topics of 'Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients'. Together they form a unique fingerprint.

    Medicine & Life Sciences